CryoLife To Present at 18th Annual Piper Jaffray Health Care Conference in New York

ATLANTA, Nov. 29 /PRNewswire-FirstCall/ -- CryoLife, Inc. , a biomaterials and biosurgical device company, announced today that it is scheduled to participate in the 18th Annual Piper Jaffray Health Care Conference at the Pierre Hotel in New York City on Friday, December 1, 2006.

D. Ashley Lee, Executive Vice President, Chief Operating Officer and Chief Financial Officer of CryoLife, Inc. will deliver the Company's presentation beginning at approximately 11:30 a.m. EST.

CryoLife's presentation may be accessed through its website, http://www.cryolife.com/, on the Investor Relations page. An archived copy of the presentation will be available for 30 days on the websites mentioned above.

About CryoLife

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiovascular, vascular, and orthopaedic surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels and is CE marked in the European Community and approved in Canada for use in soft tissue repair and approved in Australia for use in vascular and pulmonary sealing and repair. The Company also distributes the CryoLife- O'Brien(R) stentless porcine heart valve and the SG Model 100 vascular graft, which are CE marked for distribution within the European Community.

For additional information about the Company, visit CryoLife's Web Site: http://www.cryolife.com/.

Media Contacts: D. Ashley Lee Executive Vice President, Chief Financial Officer and Chief Operating Officer Phone: [phone] Katie Brazel Fleishman Hillard Phone: [phone]